FOLETTA MARK G 4

What Happened
Mark G. Foletta, a director of AMN Healthcare Services, reported the vesting/conversion of 8,325 restricted stock units (RSUs) into common shares (reported as an "exercise/conversion of derivative" at $0.00) and a contemporaneous disposition of those 8,325 shares (also $0.00). He was also granted 8,304 new RSUs on May 1, 2026. All transactions show $0 total consideration (typical for RSU vesting and grant entries).

Key Details

• Transaction date: May 1, 2026; Form 4 filed May 4, 2026 (three days after the transaction date).
• Converted/vested: 8,325 RSUs → 8,325 shares (code M), $0.00 per share, $0 total reported.
• Disposed: 8,325 shares (code M), $0.00 per share, $0 total reported.
• New grant: 8,304 RSUs (code A) granted May 1, 2026, $0.00 per share, $0 total reported.
• Shares owned after transaction: not disclosed in the information provided.
• Footnotes: Vesting shares were RSUs (each RSU represents the right to one share). Some RSUs were from the AMN Healthcare 2017 Equity Plan (granted May 2, 2025; vest the earlier of one year after grant or the 2026 annual meeting) and others from the AMN Healthcare 2025 Equity Plan (granted May 1, 2026; vest the earlier of one year after grant or the 2027 annual meeting). RSUs do not have an expiration date.

Context

• The filing shows RSU vesting/conversion and a simultaneous disposition of the same number of shares. Filings like this commonly reflect share withholding or sale-to-cover to satisfy tax withholding obligations at vesting, though the Form 4 itself does not specify the reason.
• Grants of RSUs (code A) are awards, not open-market purchases or sales, and are routine compensation for directors/executives rather than direct market sentiment signals.